Read the v3.2 writeup → "I asked Gemma 4 to summarize. It said the transcript looked truncated. It was right." Reproducible benchmarks, a 2,048-token Ollama default that silently broke every summary, ...
Scripta Materialia is a LETTERS journal of Acta Materialia, providing a forum for the rapid publication of short communications on the relationship between the structure and the properties of ...
The paper is published in the journal Scripta Materialia. This technology is expected to significantly improve the efficiency and stability of magnets used in high-power applications such as electric ...
Integration strengthens Quantum Health's ability to help employers and members manage everyday prescription drug costs within its existing navigation experience The partnership improves Quantum Health ...
Magnesium alloys, due to their unique physical and mechanical properties including low density, exceptional shock absorption capabilities, robust electromagnetic shielding abilities, and high specific ...
Mark Davis joins as Vice President of Health Plans & Strategic Growth Steve Halleen enters as Senior Director of Consultant Relations Mark Davis, Vice President of Health Plans & Strategic Growth ...
Scripta allows consumers to compare prescription prices, coupons, and insurance options in one place, helping patients and employers find affordable meds and smarter choices. As prescription drug ...
The chief scientist at a university that plays a major role in developing China’s navy has been detained as part of an investigation into alleged academic misconduct and misuse of state research funds ...
In a world of 8 billion people, there's one thing that makes each of us unique: our fingerprints. A variety of genetic and environmental factors create tiny variations in the skin's ridges and whorls, ...
Oxford-based techbio start-up Scripta Therapeutics has announced a $12 million seed funding round helping them to reshape conventional drug discovery. Scripta’s scientific strategy centres on ...
Scripta’s unique approach is based on the concept that transcription factors, the master controllers of gene expression, are core drivers of disease and act as detailed and dynamic maps of the ...
$12 million seed funding round led by Oxford Science Enterprises and Apollo Health Ventures, with AlbionVC, YZR Capital, and Parkwalk Advisors, and support from Oxford University Innovation Scripta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results